|
|
Article: Enzon Reports Third Quarter 2009 Results.
- Article from:
- Pediatrics Week
- Article date:
- November 21, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) announced its third quarter 2009 financial results. For the three months ended September 30, 2009, Enzon reported a net income of $0.1 million or break-even on a diluted per-share basis, as compared to a net loss of $2.0 million or $0.05 on a diluted per-share basis for the third quarter of 2008. In the third quarter of 2009, the Products segment profitability grew 55% as compared to the third quarter of 2008. This was offset by a decline in revenues and profitability in the contract manufacturing segment. The Company also experienced a reduction of general and administrative costs from the third quarter of 2008. In 2008, the ...
Related newspaper, magazine, and journal articles:
|
|
Article: LTC Announces Operating Results for the Three and Nine ...
Business Wire;
October 18, 2004 ;
700+ words
... ... operations for the three and nine months ended September 30, 2004 and announced ... Revenues for the three months ended September 30, 2004, were $17 ... last year. For the nine months ended September 30, 2004, net income available ...
|
|